Organisation paid for research Program year 2025 Source: CMS Open Payments

Fellows Research Alliance Inc

Neither a doctor nor a teaching hospital

Research payments

$1,732,226

239 payments

Through program year 2025, Fellows Research Alliance Inc is reported as receiving $1,732,226 in research payments, across 239 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $93,741 20
2024 Research $175,515 50
2023 Research $371,642 33
2022 Research $595,328 37
2021 Research $131,885 31
2020 Research $122,357 16
2019 Research $241,757 52

Breakdown

Who paid Research payments · program years 2019–2025
  1. Roche Molecular Systems, Inc. $575,064 27 payments
  2. Amgen Inc. $252,654 9 payments
  3. Becton, Dickinson and Company $224,688 5 payments
  4. Vanda Pharmaceuticals Inc. $176,761 40 payments
  5. Mylan Inc. $127,158 23 payments
  6. Exeltis, USA Inc. $122,370 35 payments
  7. Sumitomo Pharma America, Inc. $107,318 42 payments
  8. Ventana Medical Systems, Inc. $76,265 34 payments
  9. Myovant Sciences GmbH $27,534 11 payments
  10. Novartis Pharmaceuticals Corporation $24,935 3 payments
Studies the money was for Research payments · program years 2019–2025
  1. Rd006250 $575,064 27 payments
  2. CovSpec $200,081 1 payment
  3. FOURIER OLE (Ph 4) $198,174 6 payments
  4. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $127,158 23 payments
  5. An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected By Motion Sickness $92,912 18 payments
  6. Rd003109 $76,265 34 payments
  7. Evaluating the Effects of Tradipitant Vs. Placebo in Atopic Dermatitis $74,749 19 payments
  8. A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles $67,583 26 payments
  9. 20160250-FOURIER OLE (Ph 4) $53,375 2 payments
  10. A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids Or Endometriosis $43,096 15 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record